Ghost Tree Capital, LLC Kura Oncology, Inc. Transaction History

Ghost Tree Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$11.78 - $16.98 $2.65 Million - $3.82 Million	-225,000 Closed	0 $0
Q4 2021 Feb 16, 2022	SELL	$12.22 - $19.57 $2.44 Million - $3.91 Million	-200,000 Reduced 47.06%	225,000 $3.15 Million
Q3 2021 Nov 15, 2021	SELL	$15.42 - $21.72 $4.24 Million - $5.97 Million	-275,000 Reduced 39.29%	425,000 $7.96 Million
Q2 2021 Aug 11, 2021	BUY	$20.85 - $29.88 $2.09 Million - $2.99 Million	100,000 Added 16.67%	700,000 $14.6 Million
Q1 2021 May 14, 2021	BUY	$24.75 - $39.14 $6.81 Million - $10.8 Million	275,000 Added 84.62%	600,000 $17 Million
Q4 2020 Feb 16, 2021	BUY	$29.0 - $41.62 $2.9 Million - $4.16 Million	100,000 Added 44.44%	325,000 $10.6 Million
Q3 2020 Nov 16, 2020	BUY	$16.3 - $30.64 $3.67 Million - $6.89 Million	225,000 New	225,000 $6.89 Million
Q4 2018 Feb 14, 2019	SELL	$10.6 - $17.49 $2.44 Million - $4.02 Million	-230,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$14.8 - $18.8 $3.4 Million - $4.32 Million	230,000 New	230,000 $4.19 Million

194

86.1M

33.6K

23.1K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $554M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.